Drug counterfeiting and decentralized whistleblowers

【Author】 Omidian, Hossein; Omidi, Yadollah

【Source】DRUG DISCOVERY TODAY

【影响因子】8.369

【Abstract】To tackle the devastating issue of drug counterfeiting, the US Food and Drug Administration (FDA) has initiated a pilot project in which 24 companies in the pharmaceutical supply chain use blockchain technology to track and trace drug deliveries among manufacturers, distributors, hospitals, clinics, and pharmacies. Although embracing new and powerful technologies is a meaningful step toward eliminating the shadow of deadly drug counterfeiting, powerful governments, and pharmaceutical giants can also take other steps to fight against drug counterfeiting. These may include helping to establish the blockchain infrastructure in low-income and underdeveloped countries, providing free or affordable original drug products to low-income countries, and allowing local drug manufacturers across the globe to manufacture affordable comparable products.

【Keywords】Drug counterfeiting; Substandard drug products; Blockchain; Smart contracts; Decentralized whistleblowers

【发表时间】2022 NOV

【收录时间】2022-10-17

【文献类型】理论模型

【主题类别】

区块链应用-实体经济-供应链